↓ Skip to main content

Cochrane Database of Systematic Reviews

Antidepressants versus placebo for people with bulimia nervosa

Overview of attention for article published in Cochrane database of systematic reviews, October 2003
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

blogs
1 blog
twitter
1 tweeter
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
141 Dimensions

Readers on

mendeley
187 Mendeley
Title
Antidepressants versus placebo for people with bulimia nervosa
Published in
Cochrane database of systematic reviews, October 2003
DOI 10.1002/14651858.cd003391
Pubmed ID
Authors

Josué Bacaltchuk, Phillipa PJ Hay

Abstract

Bulimia Nervosa (BN) represents an important public health problem and is related to serious morbidity and even mortality. This review attempted to systematically evaluate the use of antidepressant medications compared with placebo for the treatment of bulimia nervosa.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
Argentina 1 <1%
Canada 1 <1%
Brazil 1 <1%
Unknown 183 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 16%
Student > Ph. D. Student 25 13%
Researcher 22 12%
Student > Bachelor 20 11%
Other 14 7%
Other 36 19%
Unknown 41 22%
Readers by discipline Count As %
Medicine and Dentistry 57 30%
Psychology 31 17%
Nursing and Health Professions 8 4%
Social Sciences 6 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 29 16%
Unknown 51 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2022.
All research outputs
#2,643,751
of 21,756,717 outputs
Outputs from Cochrane database of systematic reviews
#5,309
of 12,100 outputs
Outputs of similar age
#16,484
of 142,819 outputs
Outputs of similar age from Cochrane database of systematic reviews
#29
of 83 outputs
Altmetric has tracked 21,756,717 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,100 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.6. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 142,819 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.